In the present study, we report on the overexpression of B7-H3 in various sarcoma subtypes and the development of an Fc-optimized B7-H3 mAb, which was characterized with regard to its potential to induce ADCC of NK cells against sarcoma cells. This evidence concerns the gene CD276 and sarcoma.